Brian Dorsey

Mr. Brian T.
Dorsey is a Chief Operating Officer at ARS Pharmaceuticals, Inc., an Advisor at Moterum Technologies, Inc., a Partner at Magnasci Ventures and a SVP-Operations & Project Management at ARS Pharmaceuticals Operations, Inc. He is on the Board of Directors at Forge Therapeutics, Inc., Blacksmith Medicines, Inc., Forward Sciences and Neurana Pharmaceuticals, Inc. Mr. Dorsey was previously employed as a Chief Development Officer & Senior Vice President by Apricus Biosciences, Inc., a Senior Vice President-Pharmaceutical Development by Golf Trust of America, Inc., a Senior Vice President-Technical Operations by Somaxon Pharmaceuticals, Inc., a Head-Project Management & Medical Writing by Maxim Pharmaceuticals, Inc., a Director & Head-Biopharmaceutical Project by Baxter BioScience Corp., a Manager-Chemistry, Manufacturing & Control by Chugai Biopharmaceuticals, Inc., a Co-Founder by Kalyra Pharmaceuticals, Inc., a Project Director & Global Project Leader by Pfizer (St. Louis), a Chief Development Officer & Senior Vice President by Seelos Therapeutics, Inc., a Founder by Septum Solutions LLC, and a Co-Founder by Sorriso Pharmaceuticals, Inc. He also served on the board at Cell Machines, Inc., Tao Life Sciences and Agouron Global Commercial Operations.
He received his undergraduate degree from the University of San Diego and a graduate degree from the University of San Diego.